BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21358190)

  • 21. Management of the patient and family with neurofibromatosis 2: a consensus conference statement.
    Evans DG; Baser ME; O'Reilly B; Rowe J; Gleeson M; Saeed S; King A; Huson SM; Kerr R; Thomas N; Irving R; MacFarlane R; Ferner R; McLeod R; Moffat D; Ramsden R
    Br J Neurosurg; 2005 Feb; 19(1):5-12. PubMed ID: 16147576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofibromatosis type 2 discordance in monozygous twins.
    Amico S; Smith P; Tobi S; Perry M; Wallace A; Evans DG
    Fam Cancer; 2020 Jan; 19(1):37-40. PubMed ID: 31965447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [NF2: ocular, neural and genetic manifestations].
    Feucht M; Mautner VF; Richard G
    Klin Monbl Augenheilkd; 2005 Apr; 222(4):312-6. PubMed ID: 15844040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
    Kluwe L; Mautner V; Heinrich B; Dezube R; Jacoby LB; Friedrich RE; MacCollin M
    J Med Genet; 2003 Feb; 40(2):109-14. PubMed ID: 12566519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome from surgery for vestibular schwannomas in children.
    MacNally SP; Rutherford SA; King AT; Freeman S; Thorne J; Mawman D; O'Driscoll MP; Evans DG; Ramsden RT
    Br J Neurosurg; 2009 Jun; 23(3):226-31. PubMed ID: 19533454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of chromosome 22 deletions in schwannomas.
    Bijlsma EK; Brouwer-Mladin R; Bosch DA; Westerveld A; Hulsebos TJ
    Genes Chromosomes Cancer; 1992 Oct; 5(3):201-5. PubMed ID: 1384671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.
    Dewan R; Pemov A; Kim HJ; Morgan KL; Vasquez RA; Chittiboina P; Wang X; Chandrasekharappa SC; Ray-Chaudhury A; Butman JA; Stewart DR; Asthagiri AR
    Neuro Oncol; 2015 Apr; 17(4):566-73. PubMed ID: 25452392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurofibromatosis Type 2.
    Ardern-Holmes S; Fisher G; North K
    J Child Neurol; 2017 Jan; 32(1):9-22. PubMed ID: 27655473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
    Evans DG; Watson C; King A; Wallace AJ; Baser ME
    J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Bilateral Vestibular Schwannoma is Not Always Related to Neurofibromatosis Type 2.
    Abeshi A; Ferri GG
    J Int Adv Otol; 2023 Jun; 19(3):263-265. PubMed ID: 37272647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibromatosis type 2.
    Slattery WH
    Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.
    Warren C; James LA; Ramsden RT; Wallace A; Baser ME; Varley JM; Evans DG
    J Med Genet; 2003 Nov; 40(11):802-6. PubMed ID: 14627667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromatosis type 2.
    Asthagiri AR; Parry DM; Butman JA; Kim HJ; Tsilou ET; Zhuang Z; Lonser RR
    Lancet; 2009 Jun; 373(9679):1974-86. PubMed ID: 19476995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.
    Stivaros SM; Stemmer-Rachamimov AO; Alston R; Plotkin SR; Nadol JB; Quesnel A; O'Malley J; Whitfield GA; McCabe MG; Freeman SR; Lloyd SK; Wright NB; Kilday JP; Kamaly-Asl ID; Mills SJ; Rutherford SA; King AT; Evans DG
    J Med Genet; 2015 Aug; 52(8):557-62. PubMed ID: 26104281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofibromatosis 2.
    Hoa M; Slattery WH
    Otolaryngol Clin North Am; 2012 Apr; 45(2):315-32, viii. PubMed ID: 22483819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurofibromatosis type 2].
    Pérez-Grau M; Miró N; Prades J; Vergés J; Lareo S; Roca-Ribas F
    Acta Otorrinolaringol Esp; 2010; 61(4):306-11. PubMed ID: 20138250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further genotype--phenotype correlations in neurofibromatosis 2.
    Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
    Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
    Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
    Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.